Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

SLC6A4 STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: a case control study.

Pizzo de Castro MR, Maes M, Guembarovski RL, Ariza CB, Reiche EM, Vargas HO, Vargas MM, de Melo LG, Dodd S, Berk M, Watanabe MA, Nunes SO.

BMC Genet. 2014 Jun 27;15:78. doi: 10.1186/1471-2156-15-78.

2.

Association between the STin2 VNTR polymorphism and smoking behavior in oral cancer patients and healthy individuals.

de Lima KW, Guembarovski RL, Oda JM, Ramos G, Oliveira BV, Cavalli IJ, de Souza Fonseca Ribeiro EM, Gonçalves MS, Aoki MN, Nunes SO, Watanabe MA.

Clin Exp Med. 2012 Mar;12(1):13-9. doi: 10.1007/s10238-011-0140-y. Epub 2011 May 31.

PMID:
21626393
3.

Association between 5-hydroxytryptamine transporter gene-linked polymorphic region and smoking behavior in Chinese males.

Chu SL, Xiao D, Wang C, Jing H.

Chin Med J (Engl). 2009 Jun 20;122(12):1365-8.

PMID:
19567154
4.

Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene.

Baca-Garcia E, Vaquero-Lorenzo C, Diaz-Hernandez M, Rodriguez-Salgado B, Dolengevich-Segal H, Arrojo-Romero M, Botillo-Martin C, Ceverino A, Piqueras JF, Perez-Rodriguez MM, Saiz-Ruiz J.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):416-20. Epub 2006 Dec 13.

PMID:
17174018
5.

Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers.

Perkins KA, Lerman C, Coddington S, Jetton C, Karelitz JL, Wilson A, Jennings JR, Ferrell R, Bergen AW, Benowitz NL.

Behav Pharmacol. 2008 Sep;19(5-6):630-40. doi: 10.1097/FBP.0b013e32830c3621.

6.
7.

Lack of association between serotonin transporter gene polymorphism 5-HTTLPR and smoking among Polish population: a case-control study.

Sieminska A, Buczkowski K, Jassem E, Tkacz E.

BMC Med Genet. 2008 Aug 8;9:76. doi: 10.1186/1471-2350-9-76.

8.

The serotonin transporter gene polymorphism STin2 VNTR confers an increased risk of inconsistent response to triptans in migraine patients.

Terrazzino S, Viana M, Floriddia E, Monaco F, Mittino D, Sances G, Tassorelli C, Nappi G, Rinaldi M, Canonico PL, Genazzani AA.

Eur J Pharmacol. 2010 Sep 1;641(2-3):82-7. doi: 10.1016/j.ejphar.2010.04.049. Epub 2010 May 18.

PMID:
20488209
9.

Study of the association of serotonin transporter triallelic 5-HTTLPR and STin2 VNTR polymorphisms with lithium prophylaxis response in bipolar disorder.

Tharoor H, Kotambail A, Jain S, Sharma PS, Satyamoorthy K.

Psychiatr Genet. 2013 Apr;23(2):77-81. doi: 10.1097/YPG.0b013e32835d6fad.

PMID:
23277128
10.

STin2 VNTR polymorphism in the serotonin transporter gene and migraine: pooled and meta-analyses.

Schürks M, Rist PM, Kurth T.

J Headache Pain. 2010 Aug;11(4):317-26. doi: 10.1007/s10194-010-0230-3. Epub 2010 Jun 29. Review.

11.

Evidence of association of serotonin transporter gene polymorphisms with schizophrenia in a South Indian population.

Vijayan NN, Iwayama Y, Koshy LV, Natarajan C, Nair C, Allencherry PM, Yoshikawa T, Banerjee M.

J Hum Genet. 2009 Sep;54(9):538-42. doi: 10.1038/jhg.2009.76. Epub 2009 Aug 28.

PMID:
19713975
12.

Association between dopamine transporter genotypes and smoking cessation: a meta-analysis.

Stapleton JA, Sutherland G, O'Gara C.

Addict Biol. 2007 Jun;12(2):221-6.

PMID:
17508996
13.

Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.

David SP, Johnstone EC, Murphy MF, Aveyard P, Guo B, Lerman C, Munafò MR.

Drug Alcohol Depend. 2008 Nov 1;98(1-2):77-85. doi: 10.1016/j.drugalcdep.2008.04.013. Epub 2008 Jun 17.

14.

[Serotonin transporter gene polymorphisms in irritable bowel syndrome and their impact on tegaserod treatment].

Li YY, Nie YQ, Xie J, Tan HZ, Zhou YJ, Wang H.

Zhonghua Nei Ke Za Zhi. 2006 Jul;45(7):552-5. Chinese.

PMID:
17074108
15.

[Association of neurocognitive endophenotype and STin2 polymorphism in major depressive disorder].

Dömötör E, Sárosi A, Balogh G, Székely A, Héjjas K, Sasvári-Székely M, Faludi G.

Neuropsychopharmacol Hung. 2007 Jun;9(2):53-62. Hungarian.

16.

Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood.

Perkins KA, Lerman C, Grottenthaler A, Ciccocioppo MM, Milanak M, Conklin CA, Bergen AW, Benowitz NL.

Behav Pharmacol. 2008 Sep;19(5-6):641-9. doi: 10.1097/FBP.0b013e32830c367c.

17.

Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation.

Quaak M, van Schayck CP, Postma DS, Wagena EJ, van Schooten FJ.

Addiction. 2012 Jan;107(1):178-87. doi: 10.1111/j.1360-0443.2011.03534.x. Epub 2011 Sep 21.

PMID:
21658141
18.

Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population.

Ohmoto M, Takahashi T, Kubota Y, Kobayashi S, Mitsumoto Y.

BMC Genet. 2014 Dec 20;15:151. doi: 10.1186/s12863-014-0151-2.

19.

Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6?

Verde Z, Santiago C, Rodríguez González-Moro JM, de Lucas Ramos P, López Martín S, Bandrés F, Lucia A, Gómez-Gallego F.

Pharmacopsychiatry. 2014 Jan;47(1):33-6. doi: 10.1055/s-0033-1358393. Epub 2013 Oct 14.

PMID:
24127329
20.

Childhood adversity, serotonin transporter (5-HTTLPR) genotype, and risk for cigarette smoking and nicotine dependence in alcohol dependent adults.

Mingione CJ, Heffner JL, Blom TJ, Anthenelli RM.

Drug Alcohol Depend. 2012 Jun 1;123(1-3):201-6. doi: 10.1016/j.drugalcdep.2011.11.013. Epub 2011 Dec 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk